Search
for

    Learn

    5 / 15 results

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn GT20029

      research compound made to degrade androgen receptors in scalp

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Fluridil

      a topical anti-androgen with less systemic involvement

    Research

    5 / 1000+ results

    Community Join

    5 / 694 results

      community If dutesteride and oral minoxidil doesn’t work that’s it right?

      in Treatment  20 upvotes 6 months ago
      A user is experiencing continued hair loss despite using 0.5mg dutasteride and 2.5mg minoxidil, and is seeking advice on why the treatments aren't working and how to address potential androgen receptor sensitivity. Replies suggest getting tested and considering scalp micropigmentation (SMP).

      community Physician here AMA – 30M oral Fin 1-1.25 mg daily

      in Update  47 upvotes 2 years ago
      Hair loss treatments, specifically the use of finasteride, microneedling and potentially oral minoxidil. People discussed their experiences with finasteride, its effects on sexual behaviors, as well as potential solutions such as tadalafil or using other growth factor signal peptides for hope in curing male pattern baldness.

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 1 month ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

      community Kintor develop GT20026 Anti-Androgen receptor drug with NO SIDES

      in Treatment  16 upvotes 3 years ago
      The conversation discusses GT20029, a new topical drug for hair loss and acne without notable side effects, which has been accepted for investigational use in China. Some users express skepticism about the legitimacy of the company and the potential for other drugs like RU58841 to be developed due to patent expiration and lack of profitability.